Effects of ephedra on autonomic nervous modulation in healthy young adults

Journal of Ethnopharmacology

Volumn 130, Issue 3, 2010, Pages 563-568

  Chen, Wei Lung ^a,b,c   Tsai, Tung Hu ^a,d   Yang, Cheryl C H ^a,d   Kuo, Terry B J ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Adverse effect; Autonomic nervous system; Ephedra; Heart rate variability; Sympathetic agent; Traditional Chinese medicine

Indexed keywords

EPHEDRA SINICA EXTRACT; PLACEBO; HERBACEOUS AGENT; PLANT EXTRACT;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART RATE VARIABILITY; HUMAN; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; CHEMISTRY; DRUG EFFECTS; EPHEDRA SINICA; HEART RATE; PROCEDURES; SPECTROSCOPY; TIME; YOUNG ADULT;

ADULT; AUTONOMIC NERVOUS SYSTEM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; EPHEDRA SINICA; FEMALE; HEART RATE; HUMANS; MALE; PLANT EXTRACTS; SPECTRUM ANALYSIS; TIME FACTORS; YOUNG ADULT;

EPHEDRA;

EID: 77954954792     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.05.056     Document Type: Article

References (25)

1. Andraws R., Chawla P., Brown D.L. Cardiovascular effects of ephedra alkaloids: a comprehensive review. Progress in Cardiovascular Disease 2005, 47:217-225.
2. Betz J.M., Gay M.L., Mossoba M.M., Adams S., Portz B.S. Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing Ma Huang. The Journal of AOAC International 1997, 80:303-315.
3. Boozer C.N., Nasser J.A., Heymsfield S.B., Wang V., Chen G., Solomon J.L. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. International Journal of Obesity and Related Metabolic Disorders 2001, 25:316-324.
4. Boozer C.N., Daly P.A., Homel P., Solomon J.L., Blanchard D., Nasser J.A., Strauss R., Meredith T. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficiency trial. International Journal of Obesity and Related Metabolic Disorders 2002, 26:593-604.
5. Curtis B.M., O'keefe J.H. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clinic Proceedings 2002, 77:45-54.
6. Caron M.F., Dore D.D., Min B., Kluger J., Boguk I., White C.M. Electrocardiographic and blood pressure effects of the ephedra-containing TrimSpa thermogenic herbal compound in healthy volunteers. Pharmacotherapy 2006, 26:1241-1246.
7. Dunnick J.K., Kissling G., Gerken D.K., Vallant M.A., Nyska A. Cardiotoxicity of Ma Huang/caffeine or ephedrine/caffeine in a rodent model system. Toxicologic Pathology 2007, 35:657-664.
8. Gurley B.J., Wang P., Gardner S.F. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (ma huang) as determined by high performance liquid chromatography. Journal Pharmaceutical Sciences 1998, 87:1547-1553.
9. Gurley B.J., Gardner S.F., Hubbard M.A. Content versus label claims in ephedra-containing dietary supplements. American Journal of Health-System Pharmacy 2000, 57:963-969.
10. Haller C.A., Benowitz N. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. The New England Journal of Medicine 2000, 343:1833-1838.
11. Haller C.A., Jacob P., Benowitz N.L. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clinical Pharmacology and Therapeutics 2002, 71:421-432.
12. Haller C.A., Meier K.H., Olson K.R. Seizures reported in association with use of dietary supplements. Clinical Toxicology 2005, 1:23-30.
13. Haller C.A., Jacob P., Benowitz N.L. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations. Clinical Pharmacology and Therapeutics 2005, 77:560-571.
14. Holstege C.P., Mitchell K., Barlotta K., Furbee R.B. Toxicity and drug interactions associated with herbal products: ephedra and St. John's wort. Medical Clinics of North America 2005, 89:1225-1257.
15. Howden R., Hanlon P.R., Petranka J.G., Kleeberger S., Bucher J., Dunnick J., Nyska A., Murphy E. Ephedrine plus caffeine causes age-dependent cardiovascular responses in Fischer 344 rats. American Journal of Physiology: Heart and Circulatory Physiology 2005, 288:H2219-H2224.
16. Kleiger R.E., Stein P.K., Bigger J.T. Heart rate variability: measurement and clinical utility. Annals of Noninvasive Electrocardiology 2005, 10:88-101.
17. Moolenaar M., Desmond P.A., Mascord D.J., Starmer G.A., Tattam B., Volkerts E.R. The effects of ephedrine on the development of fatigue in a prolonged driving-related task. Human Psychopharmacology 1999, 14:415-427.
18. McBride B.F., Karapanos A.K., Krudysz A., Kluger J., Coleman C.I., White C.M. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine. The Journal of the American Medical Association 2004, 291:216-221.
19. Mehendale S.R., Bauer B.A., Yuan C.S. Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine. The American Journal of Chinese Medicine 2004, 32:1-10.
20. Nyska A., Murphy E., Foley J.F., Collins B.J., Petranka J., Howden R., Hanlon P., Dunnick J.K. Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. Toxicological Sciences 2005, 83:388-396.
21. Pomeranz B., Macaulay R.J., Caudill M.A., Kutz I., Adam D., Gordon D., Kilborn K.M., Barger A.C., Shannon D.C., Cohen R.J., Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. American Journal of Physiology: Heart and Circulatory Physiology 1985, 248:H151-H153.
22. Soni M.G., Carabin I.G., Griffiths J.C., Burdock G.A. Safety of ephedra: lesions learned. Toxicology Letters 2004, 150:97-110.
23. Su C.F., Kuo T.B.J., Kuo J.S., Lai H.Y., Chen H.I. Sympathetic and parasympathetic activities evaluated by heart-rate variability in head injury of various severities. Clinical Neurophysiology 2005, 116:1273-1279.
24. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996, 93:1043-1065.
25. Vukovich M.D., Schoorman R., Heilman C., Jacob P., Benowitz N.L. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure. Clinical and Experimental Pharmacology and Physiology 2005, 32:47-53.